Novyra Pharmachem Board Meeting Postponed to April 25

Novyra Pharmachem postpones its board meeting originally scheduled for April 18, 2026 to April 25, 2026.
The meeting was intended to consider and approve audited financial results for Q4 and FY ending March 31, 2026.
This intimation is made pursuant to Regulation 29 of SEBI Listing Obligations and Disclosure Requirements, 2015.
The company requests BSE to take this revised schedule on record for regulatory compliance purposes.